Profile data is unavailable for this security.
About the company
Natera, Inc. provides cell-free DNA (cfDNA) and genetic testing, dedicated to oncology, women’s health, and organ health. The Company's cfDNA technology platform combines novel molecular biology techniques with bioinformatics software and artificial intelligence. It has leveraged its platform to develop non-invasive prenatal test on the market (Panorama), the first tumor-specific assay for truly individualized cancer care (Signatera), best-in-class rejection assessment for kidney transplantation (Prospera) and others. In the women’s health space, it develops and commercializes non- or minimally- invasive tests to evaluate risk for, and thereby enable early detection of, a range of genetic conditions, such as Down syndrome. In oncology, it is focused on detecting molecular residual disease and recurrence monitoring in solid tumors, among others. In organ health, it offers tests to assess kidney, heart, and lung transplant rejection as well as genetic testing for chronic kidney disease.
- Revenue in USD (TTM)2.31bn
- Net income in USD-208.16m
- Incorporated2007
- Employees6.14k
- LocationNatera Inc13011 MCCALLEN PASSBUILDING A SUITE 100AUSTIN 78753United StatesUSA
- Phone+1 (650) 249-9090
- Fax+1 (302) 674-5266
- Websitehttps://www.natera.com/
More ▼
Mergers & acquisitions
| Acquired company | NTRA:NSQ since announced | Transaction value |
|---|---|---|
| Foresight Diagnostics Inc | -14.77% | 465.12m |
Data delayed at least 15 minutes, as of Mar 04 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molina Healthcare Inc | 45.43bn | 472.00m | 7.46bn | 19.00k | 16.97 | 1.82 | 11.18 | 0.1642 | 8.54 | 8.54 | 858.31 | 79.78 | 2.91 | -- | 13.19 | 2,390,842.00 | 3.03 | 6.20 | 5.93 | 13.33 | 13.07 | 14.69 | 1.04 | 2.33 | -- | 4.08 | 0.4926 | 0.00 | 11.75 | 18.52 | -59.97 | -6.85 | 6.42 | -- |
| Brightspring Health Services Inc | 12.91bn | 106.35m | 7.87bn | 23.50k | 84.12 | 4.17 | 29.24 | 0.6094 | 0.4832 | 0.8688 | 59.17 | 9.76 | 2.09 | 15.65 | 12.79 | 549,385.70 | 1.70 | -0.5355 | 2.32 | -0.6793 | 11.76 | 14.47 | 0.8117 | -0.3312 | 1.12 | 2.51 | 0.5728 | -- | 28.18 | 18.27 | 259.99 | 38.58 | 12.96 | -- |
| Davita Inc | 13.64bn | 721.80m | 10.17bn | 78.00k | 15.93 | -- | 5.75 | 0.7456 | 9.56 | 9.91 | 179.74 | -9.50 | 0.7849 | 62.63 | 5.98 | 174,911.10 | 6.06 | 6.13 | 8.47 | 8.24 | 32.25 | 31.51 | 7.72 | 8.48 | 1.24 | 3.77 | 0.8987 | -- | 6.46 | 3.39 | -22.91 | -1.62 | -3.11 | -- |
| Encompass Health Corp | 5.94bn | 565.70m | 10.74bn | 24.61k | 19.50 | 4.43 | 9.87 | 1.81 | 5.54 | 5.53 | 58.10 | 24.38 | 0.8713 | -- | 9.75 | 241,160.50 | 11.16 | 8.11 | 14.72 | 10.27 | 95.71 | 95.51 | 12.81 | 10.58 | -- | 8.88 | 0.4319 | 19.06 | 10.46 | 10.72 | 24.14 | 23.88 | 12.52 | -8.46 |
| Ensign Group Inc | 5.06bn | 343.97m | 12.39bn | 46.00k | 36.48 | 5.55 | 27.61 | 2.45 | 5.84 | 5.84 | 85.94 | 38.42 | 0.9984 | -- | 8.38 | 109,953.10 | 6.80 | 6.66 | 8.11 | 8.05 | 21.07 | 21.89 | 6.81 | 6.82 | -- | -- | 0.0597 | 5.16 | 18.72 | 16.05 | 15.44 | 15.07 | 20.77 | 4.77 |
| Universal Health Services Inc | 17.36bn | 1.49bn | 12.51bn | 88.10k | 8.85 | 1.72 | 5.88 | 0.7206 | 23.15 | 23.15 | 269.38 | 119.15 | 1.16 | -- | 7.27 | 197,103.60 | 10.08 | 7.25 | 12.43 | 8.67 | -- | -- | 8.70 | 6.85 | 0.9803 | 12.43 | 0.3908 | 5.70 | 9.71 | 8.48 | 30.36 | 9.61 | 6.69 | 31.95 |
| Tenet Healthcare Corp | 21.31bn | 1.41bn | 21.12bn | 77.00k | 15.68 | 5.00 | 6.54 | 0.9912 | 15.49 | 15.49 | 234.60 | 48.53 | 0.7271 | 10.89 | 7.78 | 276,753.30 | 8.08 | 7.28 | 11.63 | 10.40 | 82.26 | 82.59 | 11.11 | 10.10 | 1.68 | 6.79 | 0.5948 | 0.00 | 3.07 | 3.85 | -56.03 | 28.67 | 13.34 | -- |
| Centene Corp | 194.78bn | -6.67bn | 21.55bn | 61.10k | -- | 1.08 | -- | 0.1106 | -13.62 | -13.62 | 394.60 | 40.57 | 2.45 | -- | 10.30 | 3,187,840.00 | -8.39 | 0.4693 | -15.17 | 0.7727 | 7.12 | 10.08 | -3.43 | 0.237 | -- | -0.3658 | 0.4646 | 0.00 | 19.44 | 11.88 | -301.94 | -- | -2.47 | -- |
| Humana Inc | 129.66bn | 1.19bn | 21.90bn | 67.06k | 18.51 | 1.24 | 10.29 | 0.1689 | 9.81 | 9.81 | 1,074.55 | 146.42 | 2.72 | -- | -- | 1,933,552.00 | 2.74 | 4.86 | -- | -- | -- | -- | 1.01 | 2.05 | -- | 5.40 | 0.4109 | 19.22 | 10.11 | 10.94 | -1.57 | -18.81 | -10.75 | 3.02 |
| Quest Diagnostics Inc | 11.04bn | 988.00m | 22.89bn | 46.00k | 23.73 | 3.20 | 14.54 | 2.07 | 8.78 | 8.78 | 97.65 | 65.18 | 0.6816 | 39.06 | 8.14 | 239,891.30 | 6.20 | 8.03 | 7.25 | 9.31 | 33.29 | 34.91 | 9.10 | 11.33 | 0.9609 | 6.55 | 0.4377 | 28.58 | 11.78 | 3.18 | 14.09 | -7.06 | 4.74 | 7.68 |
| Labcorp Holdings Inc | 13.95bn | 876.50m | 23.32bn | 71.00k | 27.06 | 2.70 | 14.96 | 1.67 | 10.46 | 10.46 | 166.54 | 104.86 | 0.7588 | 19.34 | 6.40 | 196,502.80 | 4.77 | 5.49 | 5.74 | 6.56 | 28.76 | 30.73 | 6.29 | 8.12 | 1.23 | 5.69 | 0.3956 | -- | 7.25 | -0.0384 | 17.49 | -10.85 | 2.63 | -- |
| Natera Inc | 2.31bn | -208.16m | 29.34bn | 6.14k | -- | 16.89 | -- | 12.72 | -1.53 | -1.53 | 16.87 | 12.26 | 1.14 | 14.36 | 7.55 | 375,894.20 | -10.26 | -25.04 | -12.72 | -31.42 | 64.75 | 56.35 | -9.03 | -28.37 | 3.24 | -- | 0.0448 | -- | 35.90 | 42.61 | -9.31 | -- | 48.00 | -- |
| Elevance Health Inc | 199.13bn | 5.66bn | 62.69bn | 96.13k | 11.31 | 1.43 | 8.63 | 0.3148 | 25.11 | 25.11 | 886.67 | 198.81 | 1.67 | -- | -- | 2,071,435.00 | 4.75 | 5.60 | -- | -- | -- | -- | 2.84 | 3.52 | -- | 5.79 | 0.4213 | 22.92 | 12.62 | 10.32 | -5.32 | 4.37 | 1.80 | 12.47 |
Data as of Mar 04 2026. Currency figures normalised to Natera Inc's reporting currency: US Dollar USD
42.86%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 11.27m | 8.15% |
| T. Rowe Price Associates, Inc. (IM)as of 31 Dec 2025 | 10.74m | 7.77% |
| JPMorgan Investment Management, Inc.as of 31 Dec 2025 | 10.47m | 7.57% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 7.09m | 5.12% |
| Wellington Management Co. LLPas of 31 Dec 2025 | 4.73m | 3.42% |
| Farallon Capital Management LLCas of 31 Dec 2025 | 3.91m | 2.83% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 3.23m | 2.33% |
| Coatue Management LLCas of 31 Dec 2025 | 2.63m | 1.90% |
| Geode Capital Management LLCas of 31 Dec 2025 | 2.61m | 1.89% |
| AQR Capital Management LLCas of 31 Dec 2025 | 2.60m | 1.88% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
